3 weeks Vertex Pharmaceuticals: Strong Execution Continued In Q3 But The Valuation Reflects ItSeeking Alpha X
3 weeks Earnings call: Supernus Pharmaceuticals reported a significant increase in total revenueInvesting.com X
3 weeks Vertex Pharmaceuticals Incorporated 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha X
3 weeks Rezdiffra Gains Traction In NASH As Madrigal Pharmaceuticals Targets European ExpansionSeeking Alpha X
3 weeks Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Raised to $441.00 at UBS GroupMarketBeat X
3 weeks Longboard Pharmaceuticals (NASDAQ:LBPH) Reaches New 1-Year High – Here’s What HappenedMarketBeat X
3 weeks Scotiabank Forecasts Strong Price Appreciation for Agios Pharmaceuticals (NASDAQ:AGIO) StockMarketBeat X
3 weeks Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price Expected to Rise, Canaccord Genuity Group Analyst SaysMarketBeat X
3 weeks Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Given Consensus Recommendation of “Moderate Buy” by AnalystsMarketBeat X
4 weeks Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks X
4 weeks AMI Asset Management Corp Purchases Shares of 51,262 Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)MarketBeat X
4 weeks DekaBank Deutsche Girozentrale Acquires 31,283 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)MarketBeat X
4 weeks Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Average Rating of “Moderate Buy” by AnalystsMarketBeat X
4 weeks Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Average Recommendation of “Buy” from AnalystsMarketBeat X
4 weeks Recursion Pharmaceuticals (NASDAQ:RXRX) Trading Down 1.6% Following Insider SellingMarketBeat X
Stock Market News